Research Topic: diagnostic testing

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

mycolabadmin

This survey asked infectious disease doctors across the United States about their use of a simple blood test (cryptococcal antigen screening) for HIV patients. The test can detect a dangerous fungal infection weeks before symptoms appear, allowing for early treatment. However, the survey found that many doctors are not using this recommended test regularly, primarily because they are unsure about its benefits and are confused about screening guidelines.

Read More »

Timely diagnosis and management of Quambalaria cyanescens-induced peritoneal dialysis peritonitis: A rare case highlighting the role of galactomannan testing

mycolabadmin

A 53-year-old man on peritoneal dialysis developed a rare fungal infection caused by Quambalaria cyanescens. Doctors used a special blood test (galactomannan testing) to quickly identify it as a fungal infection rather than a bacterial one, leading to timely removal of his dialysis catheter on day 5. After treatment with antifungal medications, he recovered completely with no relapses over two years of follow-up. This case shows the importance of proper hygiene during dialysis and using advanced diagnostic tools for rare infections.

Read More »

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

mycolabadmin

Researchers surveyed infectious disease doctors across the United States about how often they screen HIV patients for cryptococcal infections using a simple blood test. They found that only about one-third to two-thirds of doctors regularly perform this screening despite guidelines recommending it. Many doctors expressed uncertainty about whether the screening is beneficial or weren’t sure about the official recommendations, suggesting a need for better education about this potentially life-saving test.

Read More »

Emerging Infections Network Survey of Screening for Cryptococcal Antigenemia, United States, 2024

mycolabadmin

Researchers surveyed infectious disease doctors across the United States to understand how often they test HIV patients for cryptococcal antigen, a fungal infection that can be serious. The study found that doctors don’t consistently follow recommended screening guidelines, with many uncertain about the benefits of testing. Key barriers included confusion about testing recommendations and concerns about delaying HIV treatment, suggesting that doctors need better education about the importance of early detection.

Read More »

The diagnosis of mucormycosis by PCR in patients at risk: a systematic review and meta-analysis

mycolabadmin

Mucormycosis is a dangerous fungal infection that kills many patients. Traditional tests like fungal culture are slow and often miss infections. This comprehensive study of 30 research papers shows that PCR testing is very effective at detecting this fungus, with different specimen types having different success rates. Blood tests were easiest to perform and worked well for screening high-risk patients, while fluid from the lungs was the most accurate.

Read More »

Quality improvement project to reduce beta-D-glucan turnaround times in an NHS pathology network

mycolabadmin

Hospitals were taking too long to get results for a fungal blood test (beta-D-glucan) that helps doctors decide whether patients with serious infections need antifungal medicines. A UK hospital pathology network improved this by bringing the test in-house instead of sending samples to a distant reference laboratory. After implementing the new system, they cut the average wait time from over 11 days to just 2.5 days while also saving money, allowing doctors to make faster treatment decisions for critically ill patients.

Read More »
Scroll to Top